Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-12

Clinical Trial Update: Efficacy of the Erchonia Corporation THL™ for Providing Relief of Tinnitus Symptoms [NA]

View source ↗

Summary

A terminated clinical trial evaluating THL™ from Erchonia Corporation for relief of tinnitus symptoms with posted results in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • THL

Snippet

Sponsor: Erchonia Corporation | Conditions: Tinnitus | NA | Status: TERMINATED | Results posted: 2024-03-12